Emergency Clearance: Public Information Collection Requirements Submitted to the Office of Management and Budget (OMB), 57178-57179 [E9-26541]
Download as PDF
57178
Federal Register / Vol. 74, No. 212 / Wednesday, November 4, 2009 / Notices
contractors must undergo a minimum of
a FBI National Criminal Information
Check (NCIC) to receive unescorted
physical access. Temporary contractors’
Social Security Number is needed to
keep records accurate, because other
people may have the same name and
birth date. Executive Order 9397
Numbering System for Federal Accounts
Relating to Individual Persons also
allows Federal agencies to use this
number to help identify individuals in
agency records. GSA describes how
information will be maintained in the
Privacy Act system of record notice
published in the Federal Register at 73
FR 35690 on June 24, 2008.
B. Annual Reporting Burden
Respondents: 24,480.
Responses per Respondent: 1.
Hours per Response: .25.
Total Burden Hours: 6,120.
Obtaining Copies of Proposals:
Requesters may obtain a copy of the
information collection documents from
the General Services Administration,
Regulatory Secretariat (MVPR), 1800 F
Street, NW., Room 4041, Washington,
DC 20405, telephone (202) 501–4755.
Please cite OMB Control No. 3090–0283,
Temporary Contractor Information
Worksheet in all correspondence. The
form can be downloaded from the GSA
Forms Library at https://www.gsa.gov/
forms. Type GSA850 in the form search
field.
Dated: October 29, 2009.
Casey Coleman,
Chief Information Officer, U.S. General
Services Administration.
[FR Doc. E9–26469 Filed 11–3–09; 8:45 am]
BILLING CODE 6820–34–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare and Medicaid
Services
[Document Identifier: CMS–10302]
mstockstill on DSKH9S0YB1PROD with NOTICES
Emergency Clearance: Public
Information Collection Requirements
Submitted to the Office of Management
and Budget (OMB)
AGENCY: Center for Medicare and
Medicaid Services.
In compliance with the requirement
of section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995, the
Centers for Medicare and Medicaid
Services (CMS), Department of Health
and Human Services, is publishing the
following summary of proposed
collections for public comment.
Interested persons are invited to send
VerDate Nov<24>2008
16:29 Nov 03, 2009
Jkt 220001
comments regarding this burden
estimate or any other aspect of this
collection of information, including any
of the following subjects: (1) The
necessity and utility of the proposed
information collection for the proper
performance of the agency’s functions;
(2) the accuracy of the estimated
burden; (3) ways to enhance the quality,
utility, and clarity of the information to
be collected; and (4) the use of
automated collection techniques or
other forms of information technology to
minimize the information collection
burden.
We are, however, requesting an
emergency review of the information
collection referenced below. In
compliance with the requirement of
section 3506(c)(2)(A) of the Paperwork
Reduction Act of 1995, we have
submitted to the Office of Management
and Budget (OMB) the following
requirements for emergency review. We
are requesting an emergency review
because the collection of this
information is needed before the
expiration of the normal time limits
under OMB’s regulations at 5 CFR Part
1320(a)(2)(ii). This is necessary to
ensure compliance with an initiative of
the Administration. We cannot
reasonably comply with the normal
clearance procedures because use of the
normal clearance procedures is
reasonably likely to cause a statutory
deadline to be missed, stated in 5 CFR
1320.13(a)(2)(iii). The Centers for
Medicare and Medicaid Services (CMS)
is requesting that an information
collection request (ICR) for the
Collection Requirements for Compendia
for Determination of Medically-accepted
Indications for Off-label Uses of Drugs
and Biologicals in an Anti-cancer
Chemotherapeutic Regimen, be
processed under the emergency
clearance process. Approval of this
package is essential in order to comply
with the section 182(b) of MIPPA
amended Section 1861(t)(2)(B) of the
Social Security Act (42 U.S.C.
1395x(t)(2)(B)).
1. Type of Information Collection
Request: New collection; Title of
Information Collection: Collection
Requirements for Compendia for
Determination of Medically-accepted
Indications for Off-label Uses of Drugs
and Biologicals in an Anti-cancer
Chemotherapeutic Regimen Use:
Congress enacted the Medicare
Improvement of Patients and Providers
Act (MIPPA). Section 182(b) of MIPPA
amended Section 1861(t)(2)(B) of the
Social Security Act (42 U.S.C.
1395x(t)(2)(B)) by adding at the end the
following new sentence: ‘On and after
January 1, 2010, no compendia may be
PO 00000
Frm 00038
Fmt 4703
Sfmt 4703
included on the list of compendia under
this subparagraph unless the compendia
has a publicly transparent process for
evaluating therapies and for identifying
potential conflicts of interest.’ We
believe that the implementation of this
statutory provision that compendia have
a ‘‘publicly transparent process for
evaluating therapies and for identifying
potential conflicts of interests’’ is best
accomplished by amending 42 CFR
414.930 to include the MIPPA
requirements and by defining the key
components of publicly transparent
processes for evaluating therapies and
for identifying potential conflicts of
interests.
All currently listed compendia will be
required to comply with these
provisions, as of January 1, 2010, to
remain on the list of recognized
compendia. In addition, any
compendium that is the subject of a
future request for inclusion on the list
of recognized compendia will be
required to comply with these
provisions. No compendium can be on
the list if it does not fully meet the
standard described in section
1861(t)(2)(B) of the Act, as revised by
section 182(b) of the MIPPA. Form
Number: CMS–10302 (OMB#: 0938–
New); Frequency: Reporting,
Recordkeeping and Third-party
disclosure; Affected Public: Business
and other for-profits and Not-for-profit
institutions; Number of Respondents:
845; Total Annual Responses: 900; Total
Annual Hours: 5,135. (For policy
questions regarding this collection
contact Brijet Burton at 410–786–7364.
For all other issues call 410–786–1326.)
CMS is requesting OMB review and
approval of this collection by December
8, 2009, with a 180-day approval period.
Written comments and
recommendations will be considered
from the public if received by the
individuals designated below by
November 30, 2009.
To obtain copies of the supporting
statement and any related forms for the
proposed paperwork collections
referenced above, access CMS’ Web Site
address at: https://www.cms.hhs.gov/
regulations/pra or E-mail your request,
including your address, phone number,
OMB number, and CMS document
identifier, to Paperwork@cms.hhs.gov,
or call the Reports Clearance Office on
(410) 786–1326.
Interested persons are invited to send
comments regarding the burden or any
other aspect of these collections of
information requirements. However, as
noted above, comments on these
information collection and
recordkeeping requirements must be
mailed and/or faxed to the designees
E:\FR\FM\04NON1.SGM
04NON1
Federal Register / Vol. 74, No. 212 / Wednesday, November 4, 2009 / Notices
referenced below by November 30,
2009.
1. Electronically. You may submit
your comments electronically to https://
www.regulations.gov. Follow the
instructions for ‘‘Comment or
Submission’’ or ‘‘More Search Options’’
to find the information collection
document(s) accepting comments.
2. By regular mail. You may mail
written comments to the following
address: CMS, Office of Strategic
Operations and Regulatory Affairs,
Division of Regulations Development,
Attention: Document Identifier/OMB
Control Number, Room C4–26–05, 7500
Security Boulevard, Baltimore,
Maryland 21244–1850.
3. By Facsimile or E-mail to OMB.
OMB, Office of Information and
Regulatory Affairs, Attention: CMS Desk
Officer, Fax Number: (202) 395–6974, Email: OIRA_submission@omb.eop.gov.
Dated: October 21, 2009.
Michelle Shortt,
Director, Regulations Development Group,
Office of Strategic Operations and Regulatory
Affairs.
[FR Doc. E9–26541 Filed 11–3–09; 8:45 am]
BILLING CODE 4120–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2009–D–0347]
Draft Guidance for Industry: Guide to
Minimize Microbial Food Safety
Hazards of Melons; Extension of
Comment Period
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice; extension of comment
mstockstill on DSKH9S0YB1PROD with NOTICES
period.
SUMMARY: The Food and Drug
Administration (FDA) is extending to
January 4, 2010, the comment period for
the draft guidance entitled ‘‘Guidance
for Industry: Guide to Minimize
Microbial Food Safety Hazards of
Melons’’ that appeared in the Federal
Register of August 3, 2009 (74 FR
38437), as corrected on August 21, 2009
(74 FR 42311). In the notice of
availability, FDA requested comments
by November 2, 2009. The agency is
taking this action in response to
requests for an extension to allow
interested persons additional time to
submit comments.
DATES: Submit written or electronic
comments by January 4, 2010.
ADDRESSES: Submit electronic
comments to https://www.
VerDate Nov<24>2008
16:29 Nov 03, 2009
Jkt 220001
regulations.gov. Submit written
comments to the Division of Dockets
Management (HFA–305), Food and Drug
Administration, 5630 Fishers Lane, rm.
1061, Rockville, MD 20852.
FOR FURTHER INFORMATION CONTACT:
Willette Crawford, Center for Food
Safety and Applied Nutrition (HFS–
317), Food and Drug Administration,
5100 Paint Branch Pkwy., College Park,
MD 20740, 301–436–1111.
SUPPLEMENTARY INFORMATION:
In the Federal Register of August 3,
2009 (74 FR 38437), as corrected on
August 21, 2009 (74 FR 42311), FDA
published a notice of availability with a
90-day comment period to request
comments on the draft guidance entitled
‘‘Guidance for Industry: Guide to
Minimize Microbial Food Safety
Hazards of Melons’’ (the draft guidance).
Comments on the draft guidance will
inform FDA’s current thinking for
finalization of this level 1 guidance
consistent with FDA’s good guidance
practices.
The agency has received requests for
an extension of the comment period for
the draft guidance. FDA has considered
the requests and is extending the
comment period for the draft guidance
until January 4, 2010. The agency
believes that this extension allows
adequate time for interested persons to
submit comments without significantly
delaying finalization of this level 1
guidance.
II. Request for Comments
Interested persons may submit to the
Division of Dockets Management (see
ADDRESSES) written or electronic
comments on this document. Submit a
single copy of electronic comments or
two paper copies of any mailed
comments, except that individuals may
submit one paper copy. Comments are
to be identified with the docket number
found in brackets in the heading of this
document. Received comments may be
seen in the Division of Dockets
Management between 9 a.m. and 4 p.m.,
Monday through Friday.
Dated: October 30, 2009.
David Horowitz,
Assistant Commissioner for Policy.
[FR Doc. E9–26638 Filed 11–2–09; 11:15 am]
PO 00000
Frm 00039
Fmt 4703
Sfmt 4703
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2009–D–0346]
Draft Guidance for Industry: Guide to
Minimize Microbial Food Safety
Hazards of Tomatoes; Extension of
Comment Period
AGENCY:
Food and Drug Administration,
HHS.
ACTION: Notice; extension of comment
period.
I. Background
BILLING CODE 4160–01–S
57179
SUMMARY: The Food and Drug
Administration (FDA) is extending to
January 4, 2010, the comment period for
the draft guidance entitled ‘‘Guidance
for Industry: Guide to Minimize
Microbial Food Safety Hazards of
Tomatoes’’ that appeared in the Federal
Register of August 3, 2009 (74 FR
38438), as corrected on August 21, 2009
(74 FR 42311). In the notice of
availability, FDA requested comments
by November 2, 2009. The agency is
taking this action in response to
requests for an extension to allow
interested persons additional time to
submit comments.
DATES: Submit written or electronic
comments by January 4, 2010.
ADDRESSES: Submit electronic
comments to https://www.
regulations.gov. Submit written
comments to the Division of Dockets
Management (HFA–305), Food and Drug
Administration, 5630 Fishers Lane, rm.
1061, Rockville, MD 20852.
FOR FURTHER INFORMATION CONTACT:
Michelle A. Smith, Center for Food
Safety and Applied Nutrition (HFS–
317), Food and Drug Administration,
5100 Paint Branch Pkwy., College Park,
MD 20740, 301–436–2024.
SUPPLEMENTARY INFORMATION:
I. Background
In the Federal Register of August 3,
2009 (74 FR 38438), as corrected on
August 21, 2009 (74 FR 42311), FDA
published a notice of availability with a
90-day comment period to request
comments on the draft guidance entitled
‘‘Guidance for Industry: Guide to
Minimize Microbial Food Safety
Hazards of Tomatoes’’ (the draft
guidance). Comments on the draft
guidance will inform FDA’s current
thinking for finalization of this level 1
guidance consistent with FDA’s good
guidance practices.
The agency has received requests for
an extension of the comment period for
the draft guidance. FDA has considered
the requests and is extending the
E:\FR\FM\04NON1.SGM
04NON1
Agencies
[Federal Register Volume 74, Number 212 (Wednesday, November 4, 2009)]
[Notices]
[Pages 57178-57179]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-26541]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Medicare and Medicaid Services
[Document Identifier: CMS-10302]
Emergency Clearance: Public Information Collection Requirements
Submitted to the Office of Management and Budget (OMB)
AGENCY: Center for Medicare and Medicaid Services.
In compliance with the requirement of section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995, the Centers for Medicare and Medicaid
Services (CMS), Department of Health and Human Services, is publishing
the following summary of proposed collections for public comment.
Interested persons are invited to send comments regarding this burden
estimate or any other aspect of this collection of information,
including any of the following subjects: (1) The necessity and utility
of the proposed information collection for the proper performance of
the agency's functions; (2) the accuracy of the estimated burden; (3)
ways to enhance the quality, utility, and clarity of the information to
be collected; and (4) the use of automated collection techniques or
other forms of information technology to minimize the information
collection burden.
We are, however, requesting an emergency review of the information
collection referenced below. In compliance with the requirement of
section 3506(c)(2)(A) of the Paperwork Reduction Act of 1995, we have
submitted to the Office of Management and Budget (OMB) the following
requirements for emergency review. We are requesting an emergency
review because the collection of this information is needed before the
expiration of the normal time limits under OMB's regulations at 5 CFR
Part 1320(a)(2)(ii). This is necessary to ensure compliance with an
initiative of the Administration. We cannot reasonably comply with the
normal clearance procedures because use of the normal clearance
procedures is reasonably likely to cause a statutory deadline to be
missed, stated in 5 CFR 1320.13(a)(2)(iii). The Centers for Medicare
and Medicaid Services (CMS) is requesting that an information
collection request (ICR) for the Collection Requirements for Compendia
for Determination of Medically-accepted Indications for Off-label Uses
of Drugs and Biologicals in an Anti-cancer Chemotherapeutic Regimen, be
processed under the emergency clearance process. Approval of this
package is essential in order to comply with the section 182(b) of
MIPPA amended Section 1861(t)(2)(B) of the Social Security Act (42
U.S.C. 1395x(t)(2)(B)).
1. Type of Information Collection Request: New collection; Title of
Information Collection: Collection Requirements for Compendia for
Determination of Medically-accepted Indications for Off-label Uses of
Drugs and Biologicals in an Anti-cancer Chemotherapeutic Regimen Use:
Congress enacted the Medicare Improvement of Patients and Providers Act
(MIPPA). Section 182(b) of MIPPA amended Section 1861(t)(2)(B) of the
Social Security Act (42 U.S.C. 1395x(t)(2)(B)) by adding at the end the
following new sentence: `On and after January 1, 2010, no compendia may
be included on the list of compendia under this subparagraph unless the
compendia has a publicly transparent process for evaluating therapies
and for identifying potential conflicts of interest.' We believe that
the implementation of this statutory provision that compendia have a
``publicly transparent process for evaluating therapies and for
identifying potential conflicts of interests'' is best accomplished by
amending 42 CFR 414.930 to include the MIPPA requirements and by
defining the key components of publicly transparent processes for
evaluating therapies and for identifying potential conflicts of
interests.
All currently listed compendia will be required to comply with
these provisions, as of January 1, 2010, to remain on the list of
recognized compendia. In addition, any compendium that is the subject
of a future request for inclusion on the list of recognized compendia
will be required to comply with these provisions. No compendium can be
on the list if it does not fully meet the standard described in section
1861(t)(2)(B) of the Act, as revised by section 182(b) of the MIPPA.
Form Number: CMS-10302 (OMB: 0938-New); Frequency: Reporting,
Recordkeeping and Third-party disclosure; Affected Public: Business and
other for-profits and Not-for-profit institutions; Number of
Respondents: 845; Total Annual Responses: 900; Total Annual Hours:
5,135. (For policy questions regarding this collection contact Brijet
Burton at 410-786-7364. For all other issues call 410-786-1326.)
CMS is requesting OMB review and approval of this collection by
December 8, 2009, with a 180-day approval period. Written comments and
recommendations will be considered from the public if received by the
individuals designated below by November 30, 2009.
To obtain copies of the supporting statement and any related forms
for the proposed paperwork collections referenced above, access CMS'
Web Site address at: https://www.cms.hhs.gov/regulations/pra or E-mail
your request, including your address, phone number, OMB number, and CMS
document identifier, to Paperwork@cms.hhs.gov, or call the Reports
Clearance Office on (410) 786-1326.
Interested persons are invited to send comments regarding the
burden or any other aspect of these collections of information
requirements. However, as noted above, comments on these information
collection and recordkeeping requirements must be mailed and/or faxed
to the designees
[[Page 57179]]
referenced below by November 30, 2009.
1. Electronically. You may submit your comments electronically to
https://www.regulations.gov. Follow the instructions for ``Comment or
Submission'' or ``More Search Options'' to find the information
collection document(s) accepting comments.
2. By regular mail. You may mail written comments to the following
address: CMS, Office of Strategic Operations and Regulatory Affairs,
Division of Regulations Development, Attention: Document Identifier/OMB
Control Number, Room C4-26-05, 7500 Security Boulevard, Baltimore,
Maryland 21244-1850.
3. By Facsimile or E-mail to OMB. OMB, Office of Information and
Regulatory Affairs, Attention: CMS Desk Officer, Fax Number: (202) 395-
6974, E-mail: OIRA_submission@omb.eop.gov.
Dated: October 21, 2009.
Michelle Shortt,
Director, Regulations Development Group, Office of Strategic Operations
and Regulatory Affairs.
[FR Doc. E9-26541 Filed 11-3-09; 8:45 am]
BILLING CODE 4120-01-P